Efficacy and safety of pitavastatin in children and adolescents with familial hypercholesterolemia in Japan and Europe

Journal of Atherosclerosis and Thrombosis

Volumn 25, Issue 5, 2018, Pages 422-429

  Harada Shiba, Mariko ^a   Kastelein, John J P ^b   Hovingh, G Kees ^b   Ray, Kausik K ^c   Ohtake, Akira ^d   Arisaka, Osamu ^e   Ohta, Takao ^f   Okada, Tomoo ^g   Suganami, Hideki ^h   Wiegman, Albert ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e DOKKYO MEDICAL UNIVERSITY   (Japan)

^f UNIVERSITY OF THE RYUKYUS   (Japan)

^g NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h KOWA COMPANY LTD   (Japan)

Author keywords

Children; Ethnic difference; Familial hypercholesterolemia; Low density lipoprotein cholesterol; Pitavastatin

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PITAVASTATIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; QUINOLINE DERIVATIVE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADOLESCENT; ALLERGIC RHINITIS; ALLERGY; ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; EUROPE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GASTROENTERITIS; GENE MUTATION; GENETIC SCREENING; HEADACHE; HUMAN; HYPERLIPIDEMIA; JAPAN; MAJOR CLINICAL STUDY; MALE; MYALGIA; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RASH; RHINOPHARYNGITIS; SCHOOL CHILD; SPRAIN; UPPER RESPIRATORY TRACT INFECTION; VOMITING; BLOOD; COMPARATIVE STUDY; FOLLOW UP; PROGNOSIS; SAFETY;

ADOLESCENT; BIOMARKERS; CHILD; DOUBLE-BLIND METHOD; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; JAPAN; MALE; PROGNOSIS; QUINOLINES; SAFETY;

EID: 85046761999     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.42242     Document Type: Article

References (24)

1. Harada-Shiba M, Arai H, Oikawa S, Ohta T, Okada T, Okamura T, Nohara A, Bujo H, Yokote K, Wakatsuki A, Ishibashi S and Yamashita S: Guidelines for the management of familial hypercholesterolemia. J Atheroscler Thromb, 2012; 19: 1043-1060
2. Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Boren J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR and Tybjaerg-Hansen A: Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J, 2013; 34: 3478-3490a
3. Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Tada H, Nakanishi C, Mori M, Yamagishi M, Inazu A and Koizumi J: Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis, 2011; 214: 404-407
4. Zhou M and Zhao D: Familial Hypercholesterolemia in Asian Populations. J Atheroscler Thromb, 2016; 23: 539- 549
5. Harada-Shiba M, Arai H, Okamura T, Yokote K, Oikawa S, Nohara A, Okada T, Ohta T, Bujo H, Watanabe M, Wakatsuki A and Yamashita S: Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan. J Atheroscler Thromb, 2012; 19: 1019-1026
6. Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, Ose L, Averna M, Boileau C, Boren J, Bruckert E, Catapano AL, Defesche JC, Descamps OS, Hegele RA, Hovingh GK, Humphries SE, Kovanen PT, Kuivenhoven JA, Masana L, Nordestgaard BG, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AF, Steinhagen-Thiessen E, Stroes ES, Taskinen MR, Tybjaerg-Hansen A and Wiklund O: Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J, 2015; 36: 2425-2437
7. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Don-tas AS, Fidanza F, Karvonen MJ, Nedelijković S, Nissinen A and Toshima H: Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA, 1995; 274: 131-136
8. Saito I, Folsom AR, Aono H, Ozawa H, Ikebe T and Yamashita T: Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA. Int J Epidemiol, 2000; 29: 837-844
9. Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S and Kastelein JJ: Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol, 2014; 171: 309-325
10. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart L, and Blood Institute.: Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics, 2011; 128 Suppl 5: S213-S256
11. Harada-Shiba M, Ohta T, Ohtake A, Dobashi K, Nohara A, Yamashita S and Yokote K: Japan Pediatric Society and Japan Atherosclerosis Society (eds.). [2017 practice guide for the treatment of pediatric familial hypercholesterolemia in Japan], Article in Japanese, Japan Atherosclerosis Society, 2017
12. Harada-Shiba M, Arisaka O, Ohtake A, Okada T and Suganami H: Efficacy and Safety of Pitavastatin in Japanese Male Children with Familial Hypercholesterolemia. J Atheroscler Thromb, 2016; 23: 48-55
13. Braamskamp MJ, Stefanutti C, Langslet G, Drogari E, Wiegman A, Hounslow N and Kastelein JJ: Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk. J Pediatr, 2015; 167: 338-343. e5
14. Saito Y, Yamada N, Teramoto T, Itakura H, Hata Y, Nakaya N, Mabuchi H, Tushima M, Sasaki J, Goto Y and Ogawa N: Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibi-tor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison. Arzneimittelforschung, 2002; 52: 251-255
15. Stender S, Budinski D, Gosho M and Hounslow N: Pitavastatin shows greater lipid-lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidae-mia. Eur J Prev Cardiol, 2013; 20: 40-53
16. Warrington S, Nagakawa S and Hounslow N: Comparison of the pharmacokinetics of pitavastatin by formulation and ethnic group: an open-label, single-dose, two-way crossover pharmacokinetic study in healthy Caucasian and Japanese men. Clin Drug Investig, 2011; 31: 735-743
17. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics, 1992; 89: 495-501
18. Daniels SR and Greer FR: Lipid screening and cardiovascular health in childhood. Pediatrics, 2008; 122: 198-208
19. Daniels SR, Gidding SS and de Ferranti SD: Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol, 2011; 5: S30-37
20. Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Ton-stad S, Wiegman A and Drogari E: Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev, 2014; 7: CD006401
21. Kusters DM, Avis HJ, de Groot E, Wijburg FA, Kastelein JJ, Wiegman A and Hutten BA: Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia. JAMA, 2014; 312: 1055-1057
22. Miyagi Y, Harada-Shiba M and Ohta T: Effect of Statin Therapy in 4-Year-Old Dichorionic Diamniotic Twins with Familial Hypercholesterolemia Showing Multiple Xanthomas. J Atheroscler Thromb, 2016; 23: 112-117
23. Pang J, Lansberg PJ and Watts GF: International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next? J Atheroscler Thromb, 2016; 23: 505-519
24. Watts GF, Ding PY, George P, Hagger MS, Hu M, Lin J, Khoo KL, Marais AD, Miida T, Nawawi HM, Pang J, Park JE, Gonzalez-Santos LB, Su TC, Truong TH, Santos RD, Soran H, Yamashita S and Tomlinson B: Translational Research for Improving the Care of Familial Hypercholesterolemia: The "Ten Countries Study" and Beyond. J Atheroscler Thromb, 2016; 23: 891-900